Stability study of oligonucleotide drug APIs is the basis for designing appropriate formulations and developing stability measures for them, and also constitutes an important part of pre-prescription research. Moreover, stability study is an important factor deciding whether the drug concerned can be marketed, and is also an indispensable condition for popularization and application of drugs with good efficacy and low toxic and side effects.

Suzhou Olipharma provides customers with comprehensive stability study services based on the environments and conditions of product use, packaging, storage and transportation and in strict accordance with the guiding principles set forth in the Stability Testing of New Drug Substances and Products (ICH Q1A(RS) Guideline).